SPRAVATO: Transforming Major Depressive Disorder Treatment

bir ses eklendi Health

2025-08-18 14:34:16 -

The treatment landscape for Major Depressive Disorder (MDD) is evolving rapidly, with SPRAVATO commercial success marking a significant milestone. SPRAVATO (esketamine) provides rapid symptom relief, particularly for patients with treatment-resistant depression, representing a breakthrough in modern depression therapy. As part of the latest depression treatment options and therapies 2025,...

0 Yorumlar 0 hisse senetleri 35 Views 0 önizleme